The evolution and biology of SARS-CoV-2 variants
A Telenti, EB Hodcroft… - Cold Spring …, 2022 - perspectivesinmedicine.cshlp.org
Our understanding of the still unfolding severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) pandemic would have been extremely limited without the study of the …
(SARS-CoV-2) pandemic would have been extremely limited without the study of the …
Emerging biosensing technologies for the diagnostics of viral infectious diseases
Several viral infectious diseases appear limitless since the beginning of the 21st century,
expanding into pandemic lengths. Thus, there are extensive efforts to provide more efficient …
expanding into pandemic lengths. Thus, there are extensive efforts to provide more efficient …
Longitudinal analysis of antibody dynamics in COVID-19 convalescents reveals neutralizing responses up to 16 months after infection
Elucidating the dynamics of the neutralizing antibody (nAb) response in coronavirus disease
2019 (COVID-19) convalescents is crucial in controlling the pandemic and informing …
2019 (COVID-19) convalescents is crucial in controlling the pandemic and informing …
Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants
The high transmissibility of SARS-CoV-2 Omicron subvariants was generally ascribed to
immune escape. It remained unclear whether the emerging variants have gradually …
immune escape. It remained unclear whether the emerging variants have gradually …
Antinucleocapsid antibodies after SARS-CoV-2 infection in the blinded phase of the randomized, placebo-controlled mRNA-1273 COVID-19 vaccine efficacy clinical …
D Follmann, HE Janes, OD Buhule, H Zhou… - Annals of Internal …, 2022 - acpjournals.org
Background: Immunoassays for determining past SARS-CoV-2 infection have not been
systematically evaluated in vaccinated persons in comparison with unvaccinated persons …
systematically evaluated in vaccinated persons in comparison with unvaccinated persons …
[HTML][HTML] Optimizing COVID-19 vaccination programs during vaccine shortages
K Liu, Y Lou - Infectious Disease Modelling, 2022 - Elsevier
During the ongoing COVID-19 pandemic, vaccine shortages occur due to various types of
constraints, including interruptions in production/supply, higher-than-expected demands …
constraints, including interruptions in production/supply, higher-than-expected demands …
Viral and antibody dynamics of acute infection with SARS-CoV-2 omicron variant (B. 1.1. 529): a prospective cohort study from Shenzhen, China
Y Yang, L Guo, J Yuan, Z Xu, Y Gu, J Zhang… - The Lancet …, 2023 - thelancet.com
Background Elucidating viral dynamics within the host is important for designing public
health measures against SARS-CoV-2, particularly during the early stages of infection when …
health measures against SARS-CoV-2, particularly during the early stages of infection when …
Corticosteroids for COVID-19 therapy: potential implications on tuberculosis
R Gopalaswamy, S Subbian - International journal of molecular sciences, 2021 - mdpi.com
On 11 March 2020, the World Health Organization announced the Corona Virus Disease-
2019 (COVID-19) as a global pandemic, which originated in China. At the host level, COVID …
2019 (COVID-19) as a global pandemic, which originated in China. At the host level, COVID …
A mathematical model of COVID‐19 with vaccination and treatment
We formulate and theoretically analyze a mathematical model of COVID‐19 transmission
mechanism incorporating vital dynamics of the disease and two key therapeutic measures …
mechanism incorporating vital dynamics of the disease and two key therapeutic measures …
A rapid label-free disposable electrochemical salivary point-of-care sensor for SARS-CoV-2 detection and quantification
N Farsaeivahid, C Grenier, S Nazarian, ML Wang - Sensors, 2022 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic has created an urgent need for
accurate early diagnosis and monitoring. A label-free rapid electrochemical point-of-care …
accurate early diagnosis and monitoring. A label-free rapid electrochemical point-of-care …